Taffe Norman P 4
4 · GENERAC HOLDINGS INC. · Filed Jul 7, 2026
Research Summary
AI-generated summary of this filing
Generac (GNRC) President Norman Taffe Sells Shares, Exercises Options
What Happened
- Norman P. Taffe, President of Generac Home, exercised stock options and sold company shares on 2026-07-06. He exercised 250 shares at a strike price of $119.54 (cost ≈ $29,885) and sold 550 shares in open-market transactions at $256.00 per share, generating proceeds of $140,800. The filing also shows two derivative-related dispositions at $0.00 (150 and 100 shares) reported the same day.
Key Details
- Transaction date: 2026-07-06 (filed 2026-07-07 — timely)
- Exercises (code M, acquired): 150 shares @ $119.54 ($17,931) and 100 shares @ $119.54 ($11,954) — total cost ≈ $29,885
- Open-market sales (code S, disposed): 200, 100, 150, and 100 share lots at $256.00 each — total sold = 550 shares; proceeds = $140,800
- Two derivative dispositions reported at $0.00 (150 & 100 shares) — $0 proceeds
- Shares owned after transaction: Not specified in the filing
- Footnotes: F1 — 10b5-1 trading plan adopted 03-06-2026; F2 — multiple lots combined; F3 — grants have graded vesting schedules
Context
- The filing shows option exercises followed by open-market sales. Exercising options at $119.54 then selling at $256.00 effectively realizes the spread; this pattern can reflect routine exercise/sell activity or a 10b5-1 plan (not a direct endorsement of the stock). The 10b5-1 plan noted in the filing (F1) indicates at least some trades may have been preplanned. Derivative-line entries at $0.00 likely reflect conversion/settlement mechanics — see footnote F3 for graded vesting.
Insider Transaction Report
Form 4
Taffe Norman P
President Generac Home
Transactions
- Sale
Common Stock
[F1][F2]2026-07-06$256.00/sh−200$51,200→ 15,908 total - Sale
Common Stock
[F1][F2]2026-07-06$256.00/sh−100$25,600→ 15,808 total - Exercise/Conversion
Common Stock
[F1]2026-07-06$119.54/sh+150$17,931→ 15,958 total - Sale
Common Stock
[F1]2026-07-06$256.00/sh−150$38,400→ 15,808 total - Exercise/Conversion
Common Stock
[F1]2026-07-06$119.54/sh+100$11,954→ 15,908 total - Sale
Common Stock
[F1][F2]2026-07-06$256.00/sh−100$25,600→ 15,808 total - Exercise/Conversion
Stock Option (Right to Buy)
[F3]2026-07-06−150→ 2,720 totalExercise: $119.54Exp: 2033-03-01→ Common Stock (150 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F3]2026-07-06−100→ 2,620 totalExercise: $119.54Exp: 2033-03-01→ Common Stock (100 underlying)
Footnotes (3)
- [F1]Adoption date of referenced 10b5-1(c) plan is: 03-06-2026
- [F2]Multiple lots for the same price for this order have been combined.
- [F3]Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.
Signature
/s/ Raj Kanuru, Attorney in Fact|2026-07-07